Fairly easy

A patient with atrial fibrillation receives diltiazem to control the ventricular rate. Which effect explains its therapeutic action?

Correct answer: A. Slows conduction through the atrioventricular node

  • A. Slows conduction through the atrioventricular node
  • B. Increases conduction through the atrioventricular node
  • C. Stimulates the kidneys to excrete uric acid
  • D. Increases platelet production in bone marrow

Explanation

Diltiazem is a nondihydropyridine calcium channel blocker that slows atrioventricular nodal conduction and can reduce the ventricular response. It does not increase cardiac conduction or act as a diuretic.

Submitted by a TestUstad contributor and published by the TestUstad editorial teamLast updated
Report an error

The more specific you are, the faster it gets fixed. A source beats an opinion.

Prefer email? support@testustad.com

About Cardiovascular and Respiratory Drugs

Cardiovascular and respiratory drugs include antihypertensives, diuretics, antianginal agents, antiarrhythmics, cardiac glycosides, anticoagulants, bronchodilators, corticosteroids and cough medicines. Questions focus on mechanisms, indications, contraindications, toxicity and monitoring, especially the difference between drugs that reduce blood pressure, improve cardiac output or open narrowed airways.

Practise Cardiovascular and Respiratory Drugs

50 free Cardiovascular and Respiratory Drugs MCQs from Nursing Pharmacology, each with the correct answer and an explanation. Unlimited attempts, no account needed.

Discussion

Stuck on an option, or know a faster way to get there? Ask or explain it here.

No comments yet. Be the first to explain this one.

Exams that ask Nursing Pharmacology questions like this

Nursing Pharmacology is on 8 papers prepared for on TestUstad, and all of them draw the same bank, so this question is worth knowing for every one of them.

More Cardiovascular and Respiratory Drugs questions